Yale Launches Trial of GLP-1 Drug for Weight Management in Type 1 Diabetes

Researchers are testing whether a GLP-1 analogue can safely help young adults with type 1 diabetes manage weight while monitoring effects on heart health markers.

Video report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsadvancements

Key takeaways

Yale University is recruiting participants for a phase 2 trial of a GLP-1 analogue in young adults with type 1 diabetes
The trial will examine both weight management and cardiovascular risk markers in this population
GLP-1 drugs are already used for obesity treatment, but this research explores their use specifically in type 1 diabetes
This is early-stage research; results are not yet available

Testing a New Approach to Weight in Type 1 Diabetes

Yale University is conducting a phase 2 clinical trial to evaluate a GLP-1 analogue as a potential weight-management tool for young adults living with type 1 diabetes. GLP-1 drugs are medications that have shown effectiveness in helping people lose weight, but their use in the type 1 diabetes population requires careful study.

What Researchers Are Measuring

Beyond weight loss, the Yale trial is examining how the GLP-1 analogue affects heart-risk markers in participants. This focus on cardiovascular outcomes reflects the importance of understanding how any new treatment might influence broader health in people with type 1 diabetes.

Who Can Participate

The trial is actively recruiting young adults who have type 1 diabetes. If you're interested in learning more about eligibility and enrollment, you can find additional information through Yale's research channels or clinical trial databases.

Evidence label

Origin: T1D Pulse (Video report). Evidence: Video report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.